Mechanism of HOXC6 promoting the progression of prostate cancer by activating the SFRP1/Wnt/β-catenin signaling pathwayZHENG Yong-jun, LI Wen-min, ZHENG Li-chuan, ZHOU Yan-feng, WANG Jian, XIA Wei-mu, YE Wei-jing, YU Jia-shun579-587
Inflammatory factors and prostate cancer:Two-sample Mendelian randomization analysisZENG Yin, ZHANG Gan-lin, GUO Jun, YANG Meng-ping, HAN Qiang, YANG Guo-wang588-596
Clinical significance of prostatic exosomal protein and PSA in detecting prostate cancer with the PSA gray zone and PI-RADS-3 lesionsLIU Yi-yang, MAO Xing-jun, XIA Jia-dong597-603
Injection of indocyanine green by vasopuncture in fluorescence laparoscopic radical prostatectomyZHANG Wei-xin, WANG Rong-jiang, CHEN Yu, WANG Ning, YAO Jian-xiang, XIE Bing-shan604-610
Electrophysiological technique for treatment of chronic prostatiti:Curative effect observationWANG Song, HU Jian-xin, WANG Shan, PENG Chao, CAI Ji, DING Min611-615
Effect of dietary modification-assisted multimodal therapy on chronic prostatitisNAN Yu-kui, GUO Lan-ge, YAO Li-zhong, JIA Hong-liang, LI Jiu-zhi616-619
Transurethral resection of the prostate versus transurethral columnar balloon dilatation of the prostate in the treatment of benign prostatic hyperplasiaZHOU Zi-peng, DONG Yue-hua, WANG Cong-bo, ZHOU Xing-bo, SU Ze-man620-626
Genetic analysis and PGT-SR outcome of a male carrier of exceptional complex chromosome rearrangementLIU Dun, DONG Yun-qiao, CHEN chuang-qi, YU Xing-su, YAN Jin, LIU Feng-hua, ZHANG Xi-qian627-633
Therapeutic effect of Lingze Tablets on benign prostatic hyperplasia in rats:An exploration based on the VEGFA/TNF/IL-6 signaling pathwayZHANG Hua-nan, SUN Song, FENG Jun-long, LIU Yi-chen, LI Hai-song, WANG Jin-sheng, WANG Bin634-639
Effect of Xiongcan Yishen Formula on ferroptosis in mouse TM3 Leydig cells after oxidative stress injuryPENG A-jian, NING Gang, WU Hui, LI Bo-nan, SHI Ruo-bing, WANG Hao-yu, LIU Wei, TANG Xue, ZHOU Xing640-647
